There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...

A “search and destroy” treatment has been found to halt tumours in some men with incurable prostate cancer. The early-stage ...

Latest milestone underscores accelerating regulatory momentum for the company’s lead investigational Helicon peptide, following FDA Fast Track Designation in desmoid tumors CAMBRIDGE, Mass., March 11, ...

A surgeon in London has successfully removed a patient’s prostate in Gibraltar using a ...

Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," meaning they do not attract enough immune cells to mount a strong attack.

Dr. Raza Bokhari, Executive Chairman & CEO will participate in panel discussions and highlight Company's AI-enabled Drug ...

Medically reviewed by Kathleen Daly, MD One out of every eight men in the U.S. will experience prostate cancer, and that rate is increasing. Support is often needed from family members and friends ...

As part of his efforts to raise money for research on prostate cancer, Formula 1 driver Valtteri Bottas has launched a new ...

Actinium-225 is a targeted and highly-potent alpha emitter that holds promise for patients who do not respond to lutetium-177 therapy. Rahul Parikh, MD, PhD, of University of Kansas, shared his ...

The drug makes prostate cancer easier to detect and stage because it attaches to the cancer cells themselves. This marks the third PSMA‑targeted radiopharmaceutical manufactured at Huntsman Cancer ...

Scientists report landmark "evolutionary double-bind" strategy to overcome treatment resistance in prostate cancer.

The Inflation Reduction Act (IRA) represents a transformative shift in US health care policy by enabling Medicare to negotiate drug prices for high-expenditure medicatio ...